|
GB812366A
(en)
|
1955-08-18 |
1959-04-22 |
Wellcome Found |
Improvements in and relating to derivatives of pyrimidine and the preparation thereof
|
|
US5102904A
(en)
|
1989-12-08 |
1992-04-07 |
American Cyanamid Company |
N-oxygenated arylpyrrole insecticidal, acaricidal and nematicidal agents and use thereas
|
|
WO2003013518A1
(en)
*
|
2001-08-03 |
2003-02-20 |
Smithkline Beecham Corporation |
Alpha-ketoamide derivatives as cathepsin k inhibitors
|
|
WO2004021979A2
(en)
|
2002-09-06 |
2004-03-18 |
Smithkline Beecham Corporation |
PYRROLO[2, 3-d]PYRIMIDINE-4-YL AND PURIN-6-YL UREA COMPOUNDS
|
|
JP4842929B2
(ja)
|
2004-05-27 |
2011-12-21 |
ファイザー・プロダクツ・インク |
癌治療に有用なピロロピリミジン誘導体
|
|
AR054416A1
(es)
|
2004-12-22 |
2007-06-27 |
Incyte Corp |
Pirrolo [2,3-b]piridin-4-il-aminas y pirrolo [2,3-b]pirimidin-4-il-aminas como inhibidores de las quinasas janus. composiciones farmaceuticas.
|
|
WO2007012953A2
(en)
|
2005-07-29 |
2007-02-01 |
Pfizer Products Inc. |
Pyrrolo[2,3-d]pyrimidine derivatives; their intermediates and synthesis
|
|
HUE028588T2
(hu)
|
2005-12-13 |
2016-12-28 |
Incyte Holdings Corp |
Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
|
|
CN2928286Y
(zh)
|
2006-01-06 |
2007-08-01 |
水城钢铁(集团)有限责任公司 |
预入口导卫装置
|
|
HRP20120786T1
(hr)
|
2006-02-02 |
2012-11-30 |
Millennium Pharmaceuticals, Inc. |
Inhibitori aktivirajuä†eg enzima e1
|
|
WO2007129195A2
(en)
|
2006-05-04 |
2007-11-15 |
Pfizer Products Inc. |
4-pyrimidine-5-amino-pyrazole compounds
|
|
EP2740731B1
(en)
|
2007-06-13 |
2016-03-23 |
Incyte Holdings Corporation |
Crystalline salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
|
|
CL2008001709A1
(es)
|
2007-06-13 |
2008-11-03 |
Incyte Corp |
Compuestos derivados de pirrolo [2,3-b]pirimidina, moduladores de quinasas jak; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como cancer, psoriasis, artritis reumatoide, entre otras.
|
|
BRPI0815042A2
(pt)
|
2007-08-01 |
2015-02-10 |
Pfizer |
Compostos de pirazol
|
|
EA020777B1
(ru)
|
2007-11-16 |
2015-01-30 |
Инсайт Корпорейшн |
4-пиразолил-n-арилпиримидин-2-амины, 4-пиразолил-n-пиразолилпиримидин-2-амины и 4-пиразолил-n-пиридилпиримидин-2-амины в качестве ингибиторов киназ janus
|
|
MY165582A
(en)
|
2008-03-11 |
2018-04-05 |
Incyte Holdings Corp |
Azetidine and cyclobutane derivatives as jak inhibitors
|
|
CL2009001884A1
(es)
|
2008-10-02 |
2010-05-14 |
Incyte Holdings Corp |
Uso de 3-ciclopentil-3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il)propanonitrilo, inhibidor de janus quinasa, y uso de una composición que lo comprende para el tratamiento del ojo seco.
|
|
WO2010083283A2
(en)
|
2009-01-15 |
2010-07-22 |
Incyte Corporation |
Processes for preparing jak inhibitors and related intermediate compounds
|
|
CA2756250A1
(en)
|
2009-04-10 |
2010-10-14 |
Pfizer Inc. |
4,5-dihydro-1h-pyrazole compounds and their pharmaceutical uses
|
|
NZ596479A
(en)
|
2009-05-22 |
2014-01-31 |
Incyte Corp |
N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
BRPI1012108B8
(pt)
|
2009-05-22 |
2021-05-25 |
Incyte Corp |
composto 3-[4-(7h-pirrolo[2,3-d]pirimidin-4-il)-1h-pirazol-1-il]octa no- ou heptano-nitrila, sua composição, seus usos e processo para preparar um sal de ácido fosfórico
|
|
TW201113285A
(en)
|
2009-09-01 |
2011-04-16 |
Incyte Corp |
Heterocyclic derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors
|
|
EA021478B1
(ru)
|
2009-10-09 |
2015-06-30 |
Инсайт Корпорейшн |
ГИДРОКСИЛЬНЫЕ, КЕТО И ГЛЮКУРОНИДНЫЕ ПРОИЗВОДНЫЕ 3-(4-(7Н-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1Н-ПИРАЗОЛ-1-ИЛ)-3-ЦИКЛОПЕНТИЛПРОПАННИТРИЛА
|
|
JP2013510166A
(ja)
|
2009-11-06 |
2013-03-21 |
プレキシコン インコーポレーテッド |
キナーゼ調節のための化合物、方法およびその適用
|
|
EP2501236B1
(en)
|
2009-11-18 |
2017-03-29 |
Plexxikon Inc. |
N-[2-fluoro-3-(4-amino-7H-pyrrolo[2,3-d]pyrimidine-5-carbonyl)-phenyl]-4-benzenesulfonamide derivatives as Raf protein kinase modulators for the treatment of cancer
|
|
US20110207754A1
(en)
|
2010-02-18 |
2011-08-25 |
Incyte Corporation |
Cyclobutane and methylcyclobutane derivatives as janus kinase inhibitors
|
|
CA2792508C
(en)
|
2010-03-10 |
2018-01-16 |
Incyte Corporation |
Piperidin-4-yl azetidine derivatives as jak1 inhibitors
|
|
TWI510487B
(zh)
|
2010-04-21 |
2015-12-01 |
Plexxikon Inc |
用於激酶調節的化合物和方法及其適應症
|
|
EA202091303A3
(ru)
|
2010-05-21 |
2021-05-31 |
Инсайт Холдингс Корпорейшн |
Композиция ингибитора jak для местного применения
|
|
CA2818542A1
(en)
|
2010-11-19 |
2012-05-24 |
Incyte Corporation |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
|
ES2536415T3
(es)
|
2010-11-19 |
2015-05-25 |
Incyte Corporation |
Pirrolopiridinas y pirrolopirimidinas sustituidas heterocíclicas como inhibidores de JAK
|
|
US8691807B2
(en)
|
2011-06-20 |
2014-04-08 |
Incyte Corporation |
Azetidinyl phenyl, pyridyl or pyrazinyl carboxamide derivatives as JAK inhibitors
|
|
BR112014002472A2
(pt)
|
2011-08-12 |
2017-04-11 |
Nissan Chemical Ind Ltd |
"compostos heterocíclicos tricíclicos, seu uso, agente terapêutico para reumatismo articular e medicamento"
|
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
|
EP2628730B1
(en)
|
2012-02-16 |
2017-12-06 |
Noxell Corporation |
Telescoping synthesis of 5-amino-4-nitroso-1-alkyl-1h-pyrazole salts
|
|
TW201406761A
(zh)
|
2012-05-18 |
2014-02-16 |
Incyte Corp |
做爲jak抑制劑之哌啶基環丁基取代之吡咯并吡啶及吡咯并嘧啶衍生物
|
|
KR102242077B1
(ko)
|
2012-11-15 |
2021-04-20 |
인사이트 홀딩스 코포레이션 |
룩솔리티니브의 서방성 제형
|
|
CN103044286B
(zh)
*
|
2013-01-25 |
2015-04-08 |
重庆紫光化工股份有限公司 |
丙二腈的合成方法
|
|
EP3489239B1
(en)
*
|
2013-03-06 |
2021-09-15 |
Incyte Holdings Corporation |
Processes and intermediates for making a jak inhibitor
|
|
CR20190156A
(es)
|
2013-05-17 |
2019-05-16 |
Incyte Corp |
Derivados de bipirazol como inhibidores jak
|
|
MX376856B
(es)
|
2013-08-07 |
2025-03-07 |
Incyte Holdings Corp |
Formas de dosificacion de liberacion prolongada para un inhibidor de jak 1 (cinasa de janus 1).
|
|
SG11201609016VA
(en)
|
2014-04-30 |
2016-11-29 |
Incyte Corp |
Processes of preparing a jak1 inhibitor and new forms thereto
|
|
ES2874537T3
(es)
|
2014-08-21 |
2021-11-05 |
Ratiopharm Gmbh |
Sal oxalato de ruxolitinib
|
|
WO2016026975A1
(en)
|
2014-08-21 |
2016-02-25 |
Ratiopharm Gmbh |
Salt of (r)-3-(4-(7h-pyrrolo [2,3-d] pyrimidin-4-yl)-lh-pyrazol-l-yl)-3-cyclopentylpropanenitrile with benzenesulfonic acid
|
|
WO2016035014A1
(en)
|
2014-09-01 |
2016-03-10 |
Sun Pharmaceutical Industries Limited |
Processes for the preparation of ruxolitinib phosphate
|
|
WO2016063294A2
(en)
|
2014-10-20 |
2016-04-28 |
Msn Laboratories Private Limited |
Process for the preparation of (r)-3-(4-(7h-pyrrolo[2,3-d], pyrimidin-4-yl)-1 h-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate and its polymorphs thereof
|
|
JP6038111B2
(ja)
*
|
2014-12-27 |
2016-12-07 |
ヤマサ醤油株式会社 |
多置換7−デアザプリン誘導体合成のための2,6−ジクロロ−8−ヨード−7−デアザプリン
|
|
EA031895B1
(ru)
|
2015-02-24 |
2019-03-29 |
Пфайзер Инк. |
Замещенные нуклеозидные производные, полезные в качестве агентов против рака
|
|
CA2928286A1
(en)
|
2015-04-28 |
2016-10-28 |
Signa S.A. De C.V. |
Solid form of ruxolitinib phosphate
|
|
CN106397443A
(zh)
|
2015-07-17 |
2017-02-15 |
浙江九洲药业股份有限公司 |
一种吡咯嘧啶类衍生物中间体的制备方法
|
|
CZ2015575A3
(cs)
|
2015-08-26 |
2017-03-08 |
Zentiva, K.S. |
Soli 5-fluoro-3-fenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]quinazolin-4-onu a jejich příprava
|
|
ES2954596T3
(es)
|
2015-12-23 |
2023-11-23 |
Univ British Columbia |
Profármacos unidos a lípidos
|
|
ES2882118T3
(es)
|
2015-12-31 |
2021-12-01 |
Chia Tai Tianqing Pharmaceutical Group Co Ltd |
Procedimiento de síntesis de ruxolitinib
|
|
CZ201629A3
(cs)
|
2016-01-22 |
2017-08-02 |
Zentiva, K.S. |
Krystalické modifikace solí (3R)-3-cyklopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propannitrilu a způsoby jejich přípravy
|
|
CN107513069A
(zh)
|
2016-06-16 |
2017-12-26 |
正大天晴药业集团股份有限公司 |
手性吡咯并嘧啶化合物的制备方法
|
|
IN201641026603A
(cg-RX-API-DMAC10.html)
|
2016-08-04 |
2018-02-09 |
|
|
|
CN107722012B
(zh)
|
2016-08-11 |
2020-05-29 |
斯福瑞(南通)制药有限公司 |
制备4-氯-7H-吡咯并[2,3-d]嘧啶的方法
|
|
CN107759623B
(zh)
|
2016-08-23 |
2020-08-14 |
苏州旺山旺水生物医药有限公司 |
Jak抑制剂的中间体及其制备方法
|
|
CN107759601B
(zh)
|
2016-08-23 |
2020-09-11 |
苏州旺山旺水生物医药有限公司 |
一种jak抑制剂及其盐的制备方法
|
|
EP3515909A1
(en)
|
2016-09-23 |
2019-07-31 |
Cellipse |
Lim kinase inhibitors, pharmaceutical composition and method of use in limk-mediated diseases
|
|
CN109651424B
(zh)
|
2017-10-11 |
2021-01-22 |
新发药业有限公司 |
一种7-保护基-4-(1-氢-吡唑-4-基)吡咯[2,3-d]嘧啶的合成方法
|
|
CN109867675B
(zh)
*
|
2017-12-01 |
2021-01-19 |
北京普祺医药科技有限公司 |
一种吡咯并嘧啶衍生的化合物、药物组合物以及其用途
|
|
US10766900B2
(en)
|
2017-12-29 |
2020-09-08 |
Formosa Laboratories, Inc. |
Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof
|
|
MD3746429T2
(ro)
|
2018-01-30 |
2022-08-31 |
Incyte Corp |
Procedee pentru prepararea de (1-(3-fluoro-2-(trifluorometil)izonicotinil)piperidin-4-onă)
|
|
CN112041303A
(zh)
|
2018-05-21 |
2020-12-04 |
Pi工业有限公司 |
制备取代的杂环化合物的方法
|
|
EP3921318A1
(en)
|
2019-02-06 |
2021-12-15 |
Concert Pharmaceuticals Inc. |
Process for preparing enantiomerically enriched jak inhibitors
|
|
CN110724145A
(zh)
|
2019-11-01 |
2020-01-24 |
廖文杰 |
一种医药中间体4-氯吡咯并嘧啶的合成方法
|
|
IL300555A
(en)
|
2020-08-18 |
2023-04-01 |
Incyte Corp |
Process and intermediates for preparing a JAK inhibitor
|
|
CA3192055A1
(en)
|
2020-08-18 |
2022-02-24 |
Incyte Corporation |
Process and intermediates for preparing a jak1 inhibitor
|
|
CN116761792A
(zh)
*
|
2020-08-18 |
2023-09-15 |
因赛特公司 |
用于制备jak抑制剂的方法和中间体
|
|
CA3226714A1
(en)
|
2021-07-12 |
2023-01-19 |
Incyte Corporation |
Process and intermediates for preparing baricitinib
|
|
CN113480546A
(zh)
|
2021-07-30 |
2021-10-08 |
江苏君若药业有限公司 |
巴瑞克替尼及其衍生物的制备
|